Abstract:Mathematical models of viral infection have been developed, fitted to data, and provide insight into disease pathogenesis for multiple agents that cause chronic infection, including HIV, hepatitis C, and B virus. However, for agents that cause acute infections or during the acute stage of agents that cause chronic infections, viral load data are often collected after symptoms develop, usually around or after the peak viral load. Consequently, we frequently lack data in the initial phase of viral growth, i.e., when pre-symptomatic transmission events occur. Missing data may make estimating the time of infection, the infectious period, and parameters in viral dynamic models, such as the cell infection rate, difficult. However, having extra information, such as the average time to peak viral load, may improve the robustness of the estimation. Here, we evaluated the robustness of estimates of key model parameters when viral load data prior to the viral load peak is missing, when we know the values of some parameters and/or the time from infection to peak viral load. Although estimates of the time of infection are sensitive to the quality and amount of available data, particularly pre-peak, other parameters important in understanding disease pathogenesis, such as the loss rate of infected cells, are less sensitive. Viral infectivity and the viral production rate are key parameters affecting the robustness of data fits. Fixing their values to literature values can help estimate the remaining model parameters when pre-peak data is missing or limited. We find a lack of data in the pre-peak growth phase underestimates the time to peak viral load by several days, leading to a shorter predicted growth phase. On the other hand, knowing the time of infection (e.g., from epidemiological data) and fixing it results in good estimates of dynamical parameters even in the absence of early data. While we provide ways to approximate model parameters in the absence of early viral load data, our results also suggest that these data, when available, are needed to estimate model parameters more precisely. In a typical acute infection, the viral load initially surges rapidly, peaks, and subsequently declines. Data collection typically begins after symptoms appear, usually around or after the peak viral load, and thus missing the critical early phase of viral growth, when pre-symptomatic transmission occurs. In the present study, we evaluate the impact of missing pre-peak data on estimating key parameters in viral dynamic models. This lack of early data complicates estimating crucial parameters in viral dynamic models, such as the time of infection, leading to shorter predicted growth phases. We found that while model parameter estimates of the time of infection are sensitive to data quantity, parameters like the loss rate of infected cells are less affected. Conversely, knowing the time of infection and fixing it can improve the robust estimation of dynamical parameter estimates even without early data. However, incorporating additional information, such as the average time to peak viral load, can enhance parameter estimation robustness. Fixing certain parameters, such as viral infectivity and production rate, to literature values can improve parameter estimation robustness when pre-peak data is limited.

Bias in the estimation of cumulative viremia in cohort studies of HIV-infected individuals

Analysis of Repeated Measurements of HIV Viral Load as a Continuous Variable while Accounting for Missing Values

Viral load criteria and threshold optimization to improve HIV incidence assay characteristics

HIV viral exposure and mortality in a multicenter ambulatory HIV adult cohort, United States, 1995-2016

Risk Factors and Clinical Prediction Models for Low-Level Viremia in People Living with HIV Receiving Antiretroviral Therapy: an 11-Year Retrospective Study

Improving the fit of bivariate smoothing splines when estimating longitudinal immunological and virological markers in HIV patients with individual antiretroviral treatment strategies

Elevated HIV Viral Load is Associated with Higher Recombination Rate In Vivo

Low level viremia is associated with Serious Non-AIDS Events in People Living with HIV

The impact of non‐disclosure of HIV status and antiretroviral therapy on HIV recency testing and incidence algorithms

How robust are estimates of key parameters in standard viral dynamic models?

Very High Baseline HIV Viremia Impairs Efficacy of Non-Nucleoside Reverse Transcriptase Inhibitor-Based ART: a Long-Term Observation in Treatment-Naïve Patients

Simultaneous Inference for HIV Dynamic Models with Skew-t Distribution Incorporating Mismeasured Covariate and Multiple Treatment Factors

Clinical Relevance of Human Immunodeficiency Virus Low-level Viremia in the Dolutegravir era: Data From the Viral Load Cohort North-East Lesotho (VICONEL)

Integrated and Total HIV-1 DNA Predict Ex Vivo Viral Outgrowth

Longitudinal study of surrogate aging measures during human immunodeficiency virus seroconversion

Very High Baseline HIV viremia impairs efficacy of NNRTI-based ART: A long-term observation in treatment-naïve patients

Modeling dynamics of acute HIV infection incorporating density-dependent cell death and multiplicity of infection

Modeling long-term longitudinal HIV dynamics with application to an AIDS clinical study

Consequences of low-level viremia among women with HIV in the United States

Markov modelling of viral load adjusting for CD4 orthogonal variable and multivariate conditional autoregressive mapping of the HIV immunological outcomes among ART patients in Zimbabwe

Early HIV viral suppression associated with subsequent 12‐month treatment success among people living with HIV in South Africa